ESC 365 - Design of a phase 2b randomized clinical trial (ENDEAVOR) to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in HF with preserved and mildly reduced EF

HFA Premium Access

Design of a phase 2b randomized clinical trial (ENDEAVOR) to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in HF with preserved and mildly reduced EF

Session: Addressing gender differences and ethnic disparities in heart failure

Topic: Trial Design

Speaker: Professor L. Lund (Stockholm, SE)

Event: Heart Failure 2023

Congress Presentation

About the speaker

Professor Lars Lund

Karolinska University Hospital, Stockholm (Sweden)

61 presentations

10 followers

2 more presentations in this session

Gender difference in patients hospitalized for acute heart failure in Korea

Speaker: Doctor M. Kim (Seoul, KR)

Gender differences in clinical features, in-hospital mortality and 30-day readmission rates in patients above 75 years hospitalized with heart failure in Spain between 2016-2019.

Speaker: Doctor A. Esteban Fernandez (Leganes, ES)

Access the full session

Addressing gender differences and ethnic disparities in heart failure

Speakers: Professor L. Lund, Doctor M. Kim, Doctor A. Esteban Fernandez

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by